Adaptimmune slips as Barclays initiates with an underweight rating
May 28 2021 - 12:13PM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Adaptimmune Therapeutics (NASDAQ:ADAP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Adaptimmune Therapeutics (NASDAQ:ADAP)
Historical Stock Chart
From Apr 2023 to Apr 2024